{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:05:39Z","timestamp":1788444339307,"version":"build-2803163510"},"reference-count":138,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Long COVID (LC), also referred to as post-acute sequelae of SARS-CoV-2 infection, is characterized by persistent symptoms originating 3 months following acute COVID-19, lasting for at least two months and frequently affecting individuals who initially experienced mild to moderate disease. The clinical spectrum is heterogeneous, involving respiratory, cardiovascular, neurological, renal, gastrointestinal, and endocrine systems, thereby posing substantial diagnostic and therapeutic challenges. Despite extensive investigation, the precise immunopathogenic mechanisms underlying LC remain incompletely defined. Accumulating evidence suggests that LC is driven by a multifactorial interplay of persistent viral antigen reservoirs, chronic immune activation, dysregulated innate and adaptive immune responses, autoimmunity, endothelial dysfunction, microvascular injury, and aberrant tissue repair. These systemic immune perturbations manifest variably across different organs, contributing to the diverse clinical phenotypes observed. However, mechanistic clarity is hindered by heterogeneity in study designs, limited longitudinal data, and the absence of standardized immunological profiling. This narrative review provides integrative insights into the immunopathogenesis of LC, synthesizing current evidence on systemic immune dysregulation and organ-specific immunological mechanisms. A conceptual framework is proposed to facilitate a structured understanding of this complex syndrome and to guide future research toward targeted immunomodulatory strategies.<\/jats:p>","DOI":"10.3390\/v18040458","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T13:58:22Z","timestamp":1775829502000},"page":"458","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrative Insights into the Immunopathogenesis and Organ-Specific Immunological Mechanisms of Long COVID: A Narrative Review"],"prefix":"10.3390","volume":"18","author":[{"given":"Supriya","family":"Mahajan","sequence":"first","affiliation":[{"name":"Department of Microbiology, School of Medical Sciences and Research, Sharda University, Greater Noida 201306, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Numed Super Speciality Hospital, Greater Noida 201306, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Kaushik","sequence":"additional","affiliation":[{"name":"Department of Microbiology, School of Medical Sciences and Research, Sharda University, Greater Noida 201306, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","article-title":"The immunology of long COVID","volume":"23","author":"Altmann","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41577-022-00692-6","article-title":"Lessons from Long COVID: Working with patients to design better research","volume":"22","author":"Alwan","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"ofab007","DOI":"10.1093\/ofid\/ofab007","article-title":"The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study","volume":"8","author":"Blair","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Townsend, L., Dyer, A.H., Naughton, A., Kiersey, R., Holden, D., Gardiner, M., Dowds, J., O\u2019Brien, K., Bannan, C., and Nadarajan, P. (2021). Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.676932"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e140491","DOI":"10.1172\/JCI140491","article-title":"Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection","volume":"131","author":"Files","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"21447","DOI":"10.1038\/s41598-020-78506-9","article-title":"Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63","volume":"10","author":"Saletti","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-021-00749-3","article-title":"SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism","volume":"6","author":"Jing","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and Disease Severity","volume":"183","author":"Ramirez","year":"2020","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"eabl4340","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1038\/s41467-022-34895-1","article-title":"Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity","volume":"13","author":"Smith","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-021-27797-1","article-title":"Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome","volume":"13","author":"Cervia","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kwissa, M., Mathayan, M., Salunkhe, S.S., Bakthavachalam, V., Ye, Z., Sanborn, M.A., Condo, S., Upadhye, A., Nemakal, A., and Wang, H. (2026). Persistent Immune Dysregulation During Long COVID Is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins. Res. Sq.","DOI":"10.1101\/2025.08.18.670908"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e487\u201390","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Swank","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"110538","DOI":"10.1016\/j.mehy.2021.110538","article-title":"Persistent SARS-2 infections contribute to long COVID-19","volume":"149","author":"Jacobs","year":"2021","journal-title":"Med. Hypotheses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2021-324280","article-title":"Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19","volume":"71","author":"Cheung","year":"2022","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.medj.2022.04.001","article-title":"Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection","volume":"3","author":"Natarajan","year":"2022","journal-title":"Med"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S2468-1253(20)30083-2","article-title":"Prolonged presence of SARS-CoV-2 viral RNA in faecal samples","volume":"5","author":"Wu","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/j.gastro.2022.04.037","article-title":"Postacute COVID-19 Is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases","volume":"163","author":"Zollner","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","article-title":"SARS-CoV-2 infection and persistence in the human body and brain at autopsy","volume":"612","author":"Stein","year":"2022","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/10815589231158041","article-title":"The role of immune activation and antigen persistence in acute and long COVID","volume":"71","author":"Opsteen","year":"2023","journal-title":"J. Investig. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Prakash, S., Karan, S., Lekbach, Y., Tifrea, D.F., Figueroa, C.J., Ulmer, J.B., Young, J.F., Glenn, G., Gil, D., and Jones, T.M. (2025). Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID. Viruses, 17.","DOI":"10.20944\/preprints202509.1120.v1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Huang","year":"2020","journal-title":"Nat. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.xcrm.2022.100663","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Willscher","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-025-02033-0","article-title":"Persistent inflammatory cytokine signature in long Covid-19 patients: A meta-analysis","volume":"34","author":"Dornas","year":"2026","journal-title":"Inflammopharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Low, R.N., Low, R.J., and Akrami, A. (2023). A review of cytokine-based pathophysiology of Long COVID symptoms. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1011936"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hein, Z.M., Kumar, S., Che Ramli, M.D., and Che Mohd Nassir, C.M.N. (2025). Immunomodulatory Mechanisms Underlying Neurological Manifestations in Long COVID: Implications for Immune-Mediated Neurodegeneration. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136214"},{"key":"ref_31","unstructured":"Jameson, J.L., and De Groot, L.J. (2026, April 02). Adrenal physiology and the HPA axis, Endotext, Available from: National Center for Biotechnology Information: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279071\/."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/pcn.13855","article-title":"Neuroimmune pathophysiology of long COVID","volume":"79","author":"Moen","year":"2025","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41577-019-0131-x","article-title":"Cytokine-mediated communication: A quantitative appraisal of immune complexity","volume":"19","author":"Mukherjee","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Mahajan, S., Mahajan, S., and Patgiri, S. (2025). Association and Interaction of Epstein-Barr Virus with SARS-CoV-2 Infection\u2014A Review. Viruses, 17.","DOI":"10.3390\/v17070903"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"104913","DOI":"10.1016\/j.micinf.2021.104913","article-title":"NLRP3 inflammasome activation in COVID-19: An interlink between risk factors and disease severity","volume":"24","author":"Amin","year":"2022","journal-title":"Microbes Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2022.01.003","article-title":"SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway","volume":"568","author":"Xu","year":"2022","journal-title":"Virology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1073\/pnas.1919133117","article-title":"A promiscuous inflammasome sparks replication of a common tumor virus","volume":"117","author":"Burton","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(87)90216-9","article-title":"Epstein-Barr virus gp350\/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis","volume":"50","author":"Tanner","year":"1987","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kongsomros, S., Thanunchai, M., Manopwisedjaroen, S., Na-Ek, P., Wang, S.F., Taechalertpaisarn, T., and Thitithanyanont, A. (2020). Trogocytosis with monocytes associated with increased \u03b12,3 sialic acid expression on B cells during H5N1 influenza virus infection. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239488"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Barberis, E., Vanella, V.V., Falasca, M., Caneapero, V., Cappellano, G., Raineri, D., Ghirimoldi, M., De Giorgis, V., Puricelli, C., and Vaschetto, R. (2021). Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.632290"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e0019221","DOI":"10.1128\/JVI.00192-21","article-title":"Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells","volume":"95","author":"Verma","year":"2021","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/infdis\/jiac452","article-title":"Human Cytomegalovirus Infection of Epithelial Cells Increases SARS-CoV-2 Superinfection by Upregulating the ACE2 Receptor","volume":"227","author":"Perera","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e163669","DOI":"10.1172\/JCI163669","article-title":"Chronic viral coinfections differentially affect the likelihood of developing long COVID","volume":"133","author":"Peluso","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Visvabharathy, L., Zhu, C., Orban, Z.S., Yarnoff, K., Palacio, N., Jimenez, M., Lim, P.H., Penaloza-MacMaster, P., and Koralnik, I.J. (2023). Autoantibody production is enhanced after mild SARS-CoV-2 infection despite vaccination in individuals with and without long COVID. medRxiv.","DOI":"10.1101\/2023.04.07.23288243"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sotzny, F., Filgueiras, I.S., Kedor, C., Freitag, H., Wittke, K., Bauer, S., Sep\u00falveda, N., Mathias da Fonseca, D.L., Baiocchi, G.C., and Marques, A.H.C. (2022). Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.981532"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"100171","DOI":"10.1016\/j.jtauto.2022.100171","article-title":"Autoantibodies against SUMO1-DHX35 in long-COVID","volume":"5","author":"Thurner","year":"2022","journal-title":"J. Transl. Autoimmun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/infdis\/jiac372","article-title":"Low Prevalence of Interferon \u03b1 Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID","volume":"227","author":"Peluso","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Timofeeva, A.M., Aulova, K.S., Mustaev, E.A., and Nevinsky, G.A. (2025). SARS-CoV-2 Spike Protein and Molecular Mimicry: An Immunoinformatic Screen for Cross-Reactive Autoantigen Candidates. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26188793"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.2011.0065","article-title":"Cytokines in autoimmunity: Role in induction, regulation, and treatment","volume":"31","author":"Moudgil","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Surace, A.E.A., and Hedrich, C.M. (2019). The Role of Epigenetics in Autoimmune\/Inflammatory Disease. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01525"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Tate, W., Walker, M., Sweetman, E., Helliwell, A., Peppercorn, K., Edgar, C., Blair, A., and Chatterjee, A. (2022). Molecular Mechanisms of Neuroinflammation in ME\/CFS and Long COVID to Sustain Disease and Promote Relapses. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.877772"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"ref_56","first-page":"e156713","article-title":"Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome","volume":"7","author":"Jia","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s10875-021-01083-7","article-title":"Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: A Longitudinal Study","volume":"41","author":"Padilla","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Littlefield, K.M., Watson, R.O., Schneider, J.M., Neff, C.P., Yamada, E., Zhang, M., Campbell, T.B., Falta, M.T., Jolley, S.E., and Fontenot, A.P. (2022). SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog., 18.","DOI":"10.1101\/2022.02.14.480317"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"eabd3876","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"106935","DOI":"10.1016\/j.isci.2023.106935","article-title":"Biological mechanisms underpinning the development of long COVID","volume":"26","author":"Perumal","year":"2023","journal-title":"iScience"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11239-022-02766-7","article-title":"Risk of venous thromboembolic events after COVID-19 infection: A systematic review and meta-analysis","volume":"55","author":"Zuin","year":"2023","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11239-020-02318-x","article-title":"COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis","volume":"51","author":"Fan","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in Long COVID\/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijid.2021.09.043","article-title":"Mast cell activation symptoms are prevalent in Long-COVID","volume":"112","author":"Weinstock","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Theoharides, T.C., and Kempuraj, D. (2023). Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID. Cells, 12.","DOI":"10.3390\/cells12050688"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5415\/apallergy.0000000000000022","article-title":"Immunological dysfunction and mast cell activation syndrome in long COVID","volume":"13","author":"Sumantri","year":"2023","journal-title":"Asia Pac. Allergy"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijid.2020.09.016","article-title":"Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome","volume":"100","author":"Afrin","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.anai.2020.11.003","article-title":"Potential association of mast cells with coronavirus disease 2019","volume":"126","author":"Theoharides","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.23812\/20-EDIT3","article-title":"COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?","volume":"34","author":"Theoharides","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_70","first-page":"9","article-title":"Mast cells contribute to coronavirus-induced inflammation: New anti-inflammatory strategy","volume":"34","author":"Kritas","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Tan, J., Anderson, D.E., Rathore, A.P.S., O\u2019Neill, A., Mantri, C.K., Saron, W.A.A., Lee, C., Cui, C.W., Kang, A.E.Z., and Foo, R. (2021). Signatures of mast cell activation are associated with severe COVID-19. medRxiv.","DOI":"10.1101\/2021.05.31.21255594"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.pharmthera.2006.05.008","article-title":"Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models","volume":"112","author":"Miyazaki","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.HYP.33.6.1399","article-title":"Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta","volume":"33","author":"Ihara","year":"1999","journal-title":"Hypertension"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI200420805","article-title":"Involvement of chymase-mediated angiotensin II generation in blood pressure regulation","volume":"114","author":"Li","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"BSR20203092","DOI":"10.1042\/BSR20203092","article-title":"Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology","volume":"40","author":"Raha","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S2213-2600(21)00125-9","article-title":"Confronting COVID-19-associated cough and the post-COVID syndrome: Role of viral neurotropism, neuroinflammation, and neuroimmune responses","volume":"9","author":"Song","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"576","DOI":"10.7326\/M20-5661","article-title":"Sixty-Day Outcomes Among Patients Hospitalized With COVID-19","volume":"174","author":"Chopra","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e4058","DOI":"10.1093\/cid\/ciaa1792","article-title":"Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients","volume":"73","author":"Petersen","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Xie","year":"2021","journal-title":"Nature"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2213-2600(22)00127-8","article-title":"Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: A prospective observational study","volume":"10","author":"Evans","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2202226","DOI":"10.1183\/13993003.02226-2022","article-title":"Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID","volume":"61","author":"Scott","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12931-025-03200-1","article-title":"Persistence of dysfunctional immune response 12 months after SARS-CoV-2 infection and their relationship with pulmonary sequelae and long COVID","volume":"26","author":"Cruz","year":"2025","journal-title":"Respir. Res."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Colarusso, C., Maglio, A., Terlizzi, M., Vitale, C., Molino, A., Pinto, A., Vatrella, A., and Sorrentino, R. (2021). Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-\u03b2 but Higher Levels of IL-1\u03b1 and TGF-\u03b2. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121931"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"117486","DOI":"10.1016\/j.jns.2021.117486","article-title":"A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications","volume":"426","author":"Frontera","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Santinelli, L., Gentilini Cacciola, E., Bortolani, L., Ridolfi, M., Maddaloni, L., Frasca, F., Fracella, M., Bugani, G., d\u2019Ettorre, G., and Mastroianni, C.M. (2025). Long COVID and Type I IFN Signature in Working-Age Adults: A Cross-Sectional Study. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26189089"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e20201707","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Leng, A., Shah, M., Ahmad, S.A., Premraj, L., Wildi, K., Li Bassi, G., Pardo, C.A., Choi, A., and Cho, S.M. (2023). Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells, 12.","DOI":"10.3390\/cells12050816"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11940-020-00647-z","article-title":"Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System","volume":"22","author":"Lima","year":"2020","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jmv.25915","article-title":"Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","volume":"92","author":"Bryce","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10456-023-09878-5","article-title":"Damage to endothelial barriers and its contribution to long COVID","volume":"27","author":"Wu","year":"2024","journal-title":"Angiogenesis"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Stojanovic, M., Djuric, M., Nenadic, I., Bojic, S., Andrijevic, A., Popovic, A., and Pesic, S. (2025). Vascular Complications of Long COVID-From Endothelial Dysfunction to Systemic Thrombosis: A Systematic Review. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27010433"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbi.2025.07.024","article-title":"Blood-Brain barrier disruption in long COVID and cognitive correlates: A cross-sectional MRI study","volume":"129","author":"Rubin","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Popa, E., Popa, A.E., Poroch, M., Poroch, V., Ungureanu, M.I., Slanina, A.M., Bacusca, A., and Coman, E.A. (2025). The Molecular Mechanisms of Cognitive Dysfunction in Long COVID: A Narrative Review. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26115102"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e6432","DOI":"10.1590\/1414-431x20176432","article-title":"Physical exercise-induced fatigue: The role of serotonergic and dopaminergic systems","volume":"50","author":"Cordeiro","year":"2017","journal-title":"Braz. J. Med Biol. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/10738584231194927","article-title":"COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions","volume":"30","author":"Kempuraj","year":"2024","journal-title":"Neuroscientist"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"IMAG.a.23","DOI":"10.1162\/IMAG.a.23","article-title":"Long COVID-related blood-brain barrier breakdown and microstructure in older adults are modified by sex and Alzheimer\u2019s disease genetic risk","volume":"3","author":"Reas","year":"2025","journal-title":"Imaging Neurosci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1152\/physrev.00039.2016","article-title":"Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa","volume":"98","author":"Dantzer","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-1-14","article-title":"Microglia and neuroinflammation: A pathological perspective","volume":"1","author":"Streit","year":"2004","journal-title":"J. Neuroinflammation"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","article-title":"Neuroinflammation pathways: A general review","volume":"127","author":"Shabab","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: A post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Almutairi, M.M., Sivandzade, F., Albekairi, T.H., Alqahtani, F., and Cucullo, L. (2021). Neuroinflammation and Its Impact on the Pathogenesis of COVID-19. Front. Med., 8.","DOI":"10.3389\/fmed.2021.745789"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/brain\/awab302","article-title":"Acute and chronic neurological disorders in COVID-19: Potential mechanisms of disease","volume":"144","author":"Balcom","year":"2021","journal-title":"Brain"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"105921","DOI":"10.1016\/j.clineuro.2020.105921","article-title":"Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review","volume":"194","author":"Montalvan","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"eabf8396","DOI":"10.1126\/scitranslmed.abf8396","article-title":"COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters","volume":"13","author":"Lazarini","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMc2033369","article-title":"Microvascular Injury in the Brains of Patients with Covid-19","volume":"384","author":"Lee","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"17562848221118403","DOI":"10.1177\/17562848221118403","article-title":"Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis","volume":"15","author":"Choudhury","year":"2022","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.gastro.2003.08.001","article-title":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection","volume":"125","author":"Leung","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"eaao4966","DOI":"10.1126\/sciadv.aao4966","article-title":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus","volume":"3","author":"Zhou","year":"2017","journal-title":"Sci. Adv."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Bohmwald, K., Diethelm-Varela, B., Rodr\u00edguez-Guilarte, L., Rivera, T., Riedel, C.A., Gonz\u00e1lez, P.A., and Kalergis, A.M. (2024). Pathophysiological, immunological, and inflammatory features of long COVID. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1341600"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41385-020-00361-8","article-title":"The lung-gut axis during viral respiratory infections: The impact of gut dysbiosis on secondary disease outcomes","volume":"14","author":"Sencio","year":"2021","journal-title":"Mucosal Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/cid\/ciaa709","article-title":"Alterations of the Gut Microbiota in Patients with Coronavirus Disease 2019 or H1N1 Influenza","volume":"71","author":"Gu","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/gutjnl-2021-324090","article-title":"Six-month follow-up of gut microbiota richness in patients with COVID-19","volume":"71","author":"Chen","year":"2022","journal-title":"Gut"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Brogna, C., Brogna, B., Bisaccia, D.R., Lauritano, F., Marino, G., Montano, L., Cristoni, S., Prisco, M., and Piscopo, M. (2022). Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages?. Vaccines, 10.","DOI":"10.3390\/vaccines10050708"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Negrut, N., Menegas, G., Kampioti, S., Bourelou, M., Kopanyi, F., Hassan, F.D., Asowed, A., Taleouine, F.Z., Ferician, A., and Marian, P. (2024). The Multisystem Impact of Long COVID: A Comprehensive Review. Diagnostics, 14.","DOI":"10.20944\/preprints202401.0099.v1"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1681\/ASN.2021060734","article-title":"Kidney Outcomes in Long COVID","volume":"32","author":"Bowe","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/08850666211062582","article-title":"Long-Term Follow Up of Renal and Other Acute Organ Failure in Survivors of Critical Illness Due to Covid-19","volume":"37","author":"Chand","year":"2022","journal-title":"J. Intensive Care Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"152072","DOI":"10.1016\/j.scitotenv.2021.152072","article-title":"CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target","volume":"808","author":"Behl","year":"2022","journal-title":"Sci. Total Environ."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: Major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Garrett, R.E., Palacio, C.H., and Bar-Or, D. (2023). Long COVID: Is there a kidney link?. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1138644"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.ajem.2020.06.011","article-title":"Dermatologic manifestations and complications of COVID-19","volume":"38","author":"Gottlieb","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2020.1704","article-title":"Digitate Papulosquamous Eruption Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection","volume":"156","author":"Sanchez","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jid.2023.07.018","article-title":"SARS-CoV-2-Induced Vasculitic Skin Lesions Are Associated with Massive Spike Protein Depositions in Autophagosomes","volume":"144","author":"Gawaz","year":"2024","journal-title":"J. Investig. Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Vazquez, C., Swanson, S.E., Negatu, S.G., Dittmar, M., Miller, J., Ramage, H.R., Cherry, S., and Jurado, K.A. (2021). SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0253089"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/dermatopathology7010002","article-title":"Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature","volume":"7","author":"Kaya","year":"2020","journal-title":"Dermatopathology"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00011-020-01370-w","article-title":"Are the cutaneous manifestations during or due to SARS-CoV-2 infection\/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms","volume":"69","author":"Criado","year":"2020","journal-title":"Inflamm. Res."},{"key":"ref_131","first-page":"e559","article-title":"Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not \u2018varicella-like\u2019","volume":"34","author":"Birckel","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Wong, T.L., and Weitzer, D.J. (2021). Long COVID and Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS)\u2014A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina, 57.","DOI":"10.3390\/medicina57050418"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"100412","DOI":"10.1016\/j.bbih.2022.100412","article-title":"Circadian rhythm disruption in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Implications for the post-acute sequelae of COVID-19","volume":"20","author":"McCarthy","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"E7150","DOI":"10.1073\/pnas.1710519114","article-title":"Cytokine signature associated with disease severity in chronic fatigue syndrome patients","volume":"114","author":"Montoya","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"547834","DOI":"10.1155\/2015\/547834","article-title":"The Association Between Serum Cytokines and Damage to Large and Small Nerve Fibers in Diabetic Peripheral Neuropathy","volume":"2015","author":"Magrinelli","year":"2015","journal-title":"J. Diabetes Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00415-018-8748-4","article-title":"Increased pro-inflammatory cytokine gene expression in peripheral blood mononuclear cells of patients with polyneuropathies","volume":"265","author":"Langjahr","year":"2018","journal-title":"J. Neurol."},{"key":"ref_137","first-page":"1573","article-title":"Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men","volume":"83","author":"Hansen","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"165823","DOI":"10.1016\/j.bbadis.2020.165823","article-title":"Exercise-induced immune system response: Anti-inflammatory status on peripheral and central organs","volume":"1866","author":"Scheffer","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/4\/458\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:32:24Z","timestamp":1777005144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/4\/458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":138,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["v18040458"],"URL":"https:\/\/doi.org\/10.3390\/v18040458","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]}}}